IL143299A0 - Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparation - Google Patents
Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparationInfo
- Publication number
- IL143299A0 IL143299A0 IL14329999A IL14329999A IL143299A0 IL 143299 A0 IL143299 A0 IL 143299A0 IL 14329999 A IL14329999 A IL 14329999A IL 14329999 A IL14329999 A IL 14329999A IL 143299 A0 IL143299 A0 IL 143299A0
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- thiadiazolidine
- quinazolinyl
- dione
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801580 | 1998-12-01 | ||
PCT/DK1999/000663 WO2000032191A1 (en) | 1998-12-01 | 1999-11-29 | New pharmaceutical composition and the process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143299A0 true IL143299A0 (en) | 2002-04-21 |
Family
ID=8106261
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14329999A IL143299A0 (en) | 1998-12-01 | 1999-11-29 | Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparation |
IL143299A IL143299A (en) | 1998-12-01 | 2001-05-22 | Pharmaceutical preparation containing 5 - [[- [3-methyl - 4 - oxo - 3,4 - dehydro - quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine - 2,4 - deion and process for its preparation |
IL179865A IL179865A (en) | 1998-12-01 | 2006-12-05 | Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet, a powder or a capsule and process for its preparation |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL143299A IL143299A (en) | 1998-12-01 | 2001-05-22 | Pharmaceutical preparation containing 5 - [[- [3-methyl - 4 - oxo - 3,4 - dehydro - quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine - 2,4 - deion and process for its preparation |
IL179865A IL179865A (en) | 1998-12-01 | 2006-12-05 | Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet, a powder or a capsule and process for its preparation |
Country Status (21)
Country | Link |
---|---|
US (1) | US7439248B1 (cs) |
EP (1) | EP1135127B1 (cs) |
JP (2) | JP5524435B2 (cs) |
KR (1) | KR100690311B1 (cs) |
CN (1) | CN1158075C (cs) |
AT (1) | ATE316376T1 (cs) |
AU (1) | AU776299B2 (cs) |
BR (1) | BR9915835A (cs) |
CA (1) | CA2352430C (cs) |
CZ (1) | CZ300543B6 (cs) |
DE (1) | DE69929635T2 (cs) |
ES (1) | ES2257886T3 (cs) |
HU (1) | HUP0104544A3 (cs) |
IL (3) | IL143299A0 (cs) |
NO (1) | NO329909B1 (cs) |
PL (1) | PL197077B1 (cs) |
RU (1) | RU2233659C2 (cs) |
TW (1) | TWI235657B (cs) |
UA (1) | UA75569C2 (cs) |
WO (1) | WO2000032191A1 (cs) |
ZA (1) | ZA200104261B (cs) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA75569C2 (en) * | 1998-12-01 | 2006-05-15 | Reddys Lab Ltd Dr | Pharmaceutical composition of thiadiazolidinedione and method for its manufacture |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
WO2001091751A1 (en) * | 2000-05-30 | 2001-12-06 | Novo Nordisk A/S | New pharmaceutical composition and the process for its preparation |
AU2001260083A1 (en) | 2000-05-26 | 2001-12-03 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
CA2469940A1 (en) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Solid compositions comprising compounds unstable to oxygen and method for stabilizing them |
WO2006002255A2 (en) * | 2004-06-23 | 2006-01-05 | Dr. Reddy's Laboratories Ltd. | A pharmaceutical formulation of balaglitazone |
CL2008000596A1 (es) * | 2007-03-01 | 2008-09-05 | Glaxo Group Ltd | Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4280997A (en) * | 1978-12-08 | 1981-07-28 | Johannes Van Leverink | Extrusion process for the preparation of anhydrous stable lactose |
DE3433239A1 (de) * | 1984-09-11 | 1986-03-20 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung |
CA2019324C (en) * | 1989-07-10 | 1996-08-20 | Robert L. Jerzewski | Fosinopril tablet formulations |
IT1238072B (it) * | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
AU665944B2 (en) * | 1991-04-04 | 1996-01-25 | Procter & Gamble Company, The | Chewable antacid compositions |
CZ227093A3 (en) * | 1991-04-29 | 1994-03-16 | Merck & Co Inc | Mixture suitable for the preparation of tablets by direct moulding |
TW268952B (cs) * | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
ES2185666T3 (es) * | 1993-09-03 | 2003-05-01 | Smithkline Beecham Corp | Formulacion estabilizada para comprimidos. |
US5532256A (en) | 1994-05-18 | 1996-07-02 | American Home Products Corporation | New azolidinediones and thiadiazolidinediones as antihyperglycemic agents |
ES2079327B1 (es) * | 1994-12-13 | 1996-08-01 | Lilly Sa | Formulaciones farmaceuticas de cefaclor. |
DK0800384T3 (da) * | 1994-12-14 | 2001-04-17 | Enbalt Trading Ltd | Pharmaceutiske tabletformuleringer til direkte kompression |
US6395303B1 (en) * | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
JPH09249561A (ja) * | 1996-03-15 | 1997-09-22 | Teikoku Chem Ind Corp Ltd | 医薬組成物 |
HU222109B1 (hu) * | 1996-09-10 | 2003-04-28 | EGIS Gyógyszergyár Rt. | Captopriltartalmú tabletták és eljárás ezek előállítására |
IL142649A (en) * | 1996-12-31 | 2004-12-15 | Reddy Research Foundation | Azole derivatives |
WO1998045291A1 (en) | 1997-12-02 | 1998-10-15 | Dr. Reddy's Research Foundation | Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
EP0945134A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
UA75569C2 (en) * | 1998-12-01 | 2006-05-15 | Reddys Lab Ltd Dr | Pharmaceutical composition of thiadiazolidinedione and method for its manufacture |
AU2001260083A1 (en) * | 2000-05-26 | 2001-12-03 | Dr. Reddy's Research Foundation | New pharmaceutical composition and the process for its preparation |
WO2006002255A2 (en) | 2004-06-23 | 2006-01-05 | Dr. Reddy's Laboratories Ltd. | A pharmaceutical formulation of balaglitazone |
-
1999
- 1999-11-29 UA UA2001053674A patent/UA75569C2/uk unknown
- 1999-11-29 AT AT99972919T patent/ATE316376T1/de not_active IP Right Cessation
- 1999-11-29 BR BR9915835-3A patent/BR9915835A/pt not_active Application Discontinuation
- 1999-11-29 WO PCT/DK1999/000663 patent/WO2000032191A1/en active Application Filing
- 1999-11-29 PL PL348601A patent/PL197077B1/pl unknown
- 1999-11-29 CA CA002352430A patent/CA2352430C/en not_active Expired - Fee Related
- 1999-11-29 AU AU13762/00A patent/AU776299B2/en not_active Ceased
- 1999-11-29 DE DE69929635T patent/DE69929635T2/de not_active Expired - Lifetime
- 1999-11-29 HU HU0104544A patent/HUP0104544A3/hu unknown
- 1999-11-29 ES ES99972919T patent/ES2257886T3/es not_active Expired - Lifetime
- 1999-11-29 JP JP2000584886A patent/JP5524435B2/ja not_active Expired - Fee Related
- 1999-11-29 EP EP99972919A patent/EP1135127B1/en not_active Expired - Lifetime
- 1999-11-29 CZ CZ20011832A patent/CZ300543B6/cs not_active IP Right Cessation
- 1999-11-29 IL IL14329999A patent/IL143299A0/xx active IP Right Grant
- 1999-11-29 KR KR1020017006782A patent/KR100690311B1/ko not_active IP Right Cessation
- 1999-11-29 CN CNB99813970XA patent/CN1158075C/zh not_active Expired - Fee Related
- 1999-11-29 RU RU2001117850/15A patent/RU2233659C2/ru not_active IP Right Cessation
- 1999-11-30 US US09/450,609 patent/US7439248B1/en not_active Expired - Fee Related
- 1999-12-27 TW TW088123261A patent/TWI235657B/zh not_active IP Right Cessation
-
2001
- 2001-05-22 IL IL143299A patent/IL143299A/en not_active IP Right Cessation
- 2001-05-24 ZA ZA200104261A patent/ZA200104261B/en unknown
- 2001-05-31 NO NO20012673A patent/NO329909B1/no not_active IP Right Cessation
-
2006
- 2006-12-05 IL IL179865A patent/IL179865A/en not_active IP Right Cessation
-
2012
- 2012-04-06 JP JP2012087678A patent/JP2012144560A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203841A3 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
WO2000017190A3 (fr) | Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
HUP0202682A3 (en) | Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use | |
AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
HUP0303069A3 (en) | Imidazole derivatives, pharmaceutical compositions containing them and their use | |
HUP0200355A3 (en) | 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use | |
HUP0203403A3 (en) | New imidazole derivatives, pharmaceutical compositions containing them and their use | |
WO2000057900A3 (en) | Factor for regulation of neurite growth | |
HUP0204413A3 (en) | Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them | |
ZA200206905B (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same. | |
AU2001237525A1 (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
HUP0203902A3 (en) | Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use | |
IL158168A0 (en) | 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same | |
HUP0400908A3 (en) | Pyrazole compounds useful as protein kinase inhibitors, their use and pharmaceutical compositions containing them | |
HUP0103283A3 (en) | Pyrazinone protease inhibitors, pharmaceutical compositions containing them and use of the compounds | |
AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
HUP0400832A3 (en) | New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients | |
IL156662A0 (en) | Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same | |
AU2001228811A1 (en) | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient | |
AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
IL179865A0 (en) | Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet a powder or a capsule and the process for its preparation | |
AU2001268131A1 (en) | Stabilized compositions containing oxygen-labile active agents | |
HUP0202520A3 (en) | Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them | |
AU2002333373A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
HRP20040171A2 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |